Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Adlyxin (lixisenatide) / Sanofi

NCT02745470: Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain

Completed

N/A

RoW

Lixisenatide, Lyxumia® pen injection, Placebo, Normal saline injection

Seoul National University Hospital, Seoul National University

Diabetes Mellitus

12/16

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites